Catch up on the weekend’s top five stories with this list compiled by The Fly: 1. In a tweet, President Donald Trump said that, “Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!” Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). 2. Apple (AAPL) and Samsung (SSNLF) announced a deal, under which the iPhone maker will begin offering iTunes movies and TV shows on Samsung TV sets, according to Bloomberg. 3. Last summer when Apple shares soared, analysts kept raising their price targets to higher and higher levels, but this week after the company dropped a guidance bombshell, many of the same analysts slashed their forecasts, Tae Kim wrote in this week’s edition of Barron’s. In the end, investors are better off holding on anyway, he contended. While Apple’s stock performance is currently tied to iPhone sales, its future is tied to a lucrative installed base that’s estimated to be 1.3B devices, and CEO Tim Cook needs to find a better way to monetize that base with more services revenue, the publication added. 4. AT&T (T) subsidiary Warner Bros’ “Aquaman” stayed atop the chart in its third weekend with $30.7M for a North American total of $259.7M and a global tally of $940.7M. Directed by James Wan, “Aquaman” stars Jason Momoa in the titular role alongside Amber Heard, Willem Dafoe, Patrick Wilson and Dolph Lundgren. The film earned an A- CinemaScore and sports a 64% Rotten Tomatoes score. 5. Air Lease (AL), AT&T, DXC Technology (DXC), Morgan Stanley (MS), Mylan (MYL), and Navistar (NAV) saw positive mentions in Barron’s.